Recombinant Anti-CD20 x Anti-CD22 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD20 antibody variable domain are respectively connected to the N terminus of the anti-CD22 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb is designed for the research of Lymphoma; Leukemia; Antoimmune disease; Immune dysfunction disease therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY